speb/financial-data huggingface dataset:
Financial ratios for DDS — quarterly report dated 2025-07-31
Total revenue: 1536003000
Gross profit: 576697000
Operating income: 93322000
Net income: 72835000
Capital expenditures: 26674000
Operating cash flow: 86761000
Depreciation & amortization: 45036000
Net tangible assets: 1919112000
Owner earnings: 91197000
Return on net tangible assets (%): 4.752041569225767
Capex to operating income (%): 28.582756477572275
Buffett classification: The Good
Stock price: 446.77
P/E ratio: 11.521467546733891
Shares outstanding: 11630836
Book value: 1919112000
P/B ratio: 2.707663023169049
Market cap (USD): 5196308599.719999
Debt to equity: 0.28717969560921924
Current ratio: 2.682849489732057
Quick ratio: 1.4105539515516652
Effective tax rate (%): 22.99518951207908
COGS to revenue (%): 62.45469572650574
SG&A to revenue (%): 28.562183797818104
Free cash flow (dilution-adjusted): 60087000
Buyback yield (%): 0.18772942008343468
Retained earnings: 6456873000
Inventory turnover: 0.7864678852073965
Receivables turnover: 29.418581935187312
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.423704426030015
FCF margin (%): 3.9119064220577697
Revenue growth (%): -0.7089984233705738
Rule of 40 score: 3.202907998687196
Financial ratios for DDS — quarterly report dated 2025-10-31
Total revenue: 1490973000
Gross profit: 659330000
Operating income: 170192000
Net income: 129810000
Capital expenditures: 30311000
Operating cash flow: 186462000
Depreciation & amortization: 44761000
Net tangible assets: 2045046000
Owner earnings: 144260000
Return on net tangible assets (%): 7.054120054023234
Capex to operating income (%): 17.809885306007335
Buffett classification: The Great
Stock price: 574.45
P/E ratio: 11.503257871530128
Shares outstanding: 11630836
Book value: 2045046000
P/B ratio: 3.2670823737950148
Market cap (USD): 6681333740.200001
Debt to equity: 0.2682413989709767
Current ratio: 2.1924098692730873
Quick ratio: 1.0038084867335983
Effective tax rate (%): 23.102896747822996
COGS to revenue (%): 55.778541932013525
SG&A to revenue (%): 29.830385929188523
Free cash flow (dilution-adjusted): 156151000
Buyback yield (%): 0
Retained earnings: 6581999000
Inventory turnover: 0.48405624680237314
Receivables turnover: 33.20578606267121
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.966187444546379
FCF margin (%): 10.47309374482301
Revenue growth (%): -2.9316348991505876
Rule of 40 score: 7.541458845672423
Financial ratios for DDS — quarterly report dated 2026-01-31
Total revenue: 1989389000
Gross profit: 721167000
Operating income: 206651000
Net income: 203725000
Capital expenditures: 19544000
Operating cash flow: 211153000
Depreciation & amortization: 46212000
Net tangible assets: 1778970000
Owner earnings: 230393000
Return on net tangible assets (%): 12.950921038578503
Capex to operating income (%): 9.457491132392294
Buffett classification: The Great
Stock price: 606.89
P/E ratio: 12.379514194536178
Shares outstanding: 11630836
Book value: 1778970000
P/B ratio: 3.96782298748152
Market cap (USD): 7058638060.04
Debt to equity: 0.3134184387595069
Current ratio: 2.645619476678447
Quick ratio: 1.3141492366564533
Effective tax rate (%): 6.47229837893536
COGS to revenue (%): 63.74932202801966
SG&A to revenue (%): 23.559695966952667
Free cash flow (dilution-adjusted): 191609000
Buyback yield (%): 0
Retained earnings: 6312651000
Inventory turnover: 1.0558855314054307
Receivables turnover: 50.0802789245796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.939141101654706
FCF margin (%): 9.631550189530556
Revenue growth (%): 33.428908504714705
Rule of 40 score: 43.06045869424526
Financial ratios for DDS — annual report dated 2026-01-31
Total revenue: 6563336000
Gross profit: 2646474000
Operating income: 688674000
Net income: 570187000
Capital expenditures: 93382000
Operating cash flow: 717008000
Depreciation & amortization: 180862000
Net tangible assets: 1778970000
Owner earnings: 657667000
Return on net tangible assets (%): 36.96897643018151
Capex to operating income (%): 13.559681358668978
Buffett classification: The Great
Stock price: 606.89
P/E ratio: 12.379514194536178
Shares outstanding: 11630836
Book value: 1778970000
P/B ratio: 3.96782298748152
Market cap (USD): 7058638060.04
Debt to equity: 0.3134184387595069
Current ratio: 2.645619476678447
Quick ratio: 1.3141492366564533
Effective tax rate (%): 17.955880658910264
Interest coverage ratio: 16.78423630913212
COGS to revenue (%): 59.677913792620096
SG&A to revenue (%): 27.096875735144444
Free cash flow (dilution-adjusted): 623626000
Buyback yield (%): 1.5265834440502446
Retained earnings: 6312651000
Inventory turnover: 3.2610677896391467
Receivables turnover: 165.22344174806162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.45755432609062
FCF margin (%): 9.501661959710733
Revenue growth (%): -0.408104055836586
Rule of 40 score: 9.093557903874146
Financial ratios for DEA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.5
Shares outstanding: 46449374
Market cap (USD): 1881199647
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEA — annual report dated 2022-12-31
Total revenue: 293606000
Gross profit: 195925000
Operating income: 72886000
Net income: 35562000
Capital expenditures: 0
Operating cash flow: 125941000
Depreciation & amortization: 98254000
Net tangible assets: 1087599000
Owner earnings: 133816000
Return on net tangible assets (%): 12.30379947020915
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.72
P/E ratio: 34.900378867330296
Shares outstanding: 46449374
Book value: 1410982000
P/B ratio: 0.8796194942812877
Market cap (USD): 1241127273.28
Debt to equity: 0.8868794924385995
Current ratio: 0.35212010455943926
Quick ratio: 0.35212010455943926
Interest coverage ratio: 1.5383933471231372
COGS to revenue (%): 34.32695517121584
SG&A to revenue (%): 8.441584981233353
Free cash flow (dilution-adjusted): 119405000
Buyback yield (%): 0
Retained earnings: 93497000
Receivables turnover: 4.990328885867256
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7891047129234208
FCF margin (%): 40.66844683010565
Rule of 40 score: 40.66844683010565
Financial ratios for DEA — annual report dated 2023-12-31
Total revenue: 287227000
Gross profit: 184802000
Operating income: 66392000
Net income: 21060000
Capital expenditures: 0
Operating cash flow: 114479000
Depreciation & amortization: 91292000
Net tangible assets: 1173748000
Owner earnings: 112352000
Return on net tangible assets (%): 9.572071688301067
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 27.2
P/E ratio: 59.99159415004748
Shares outstanding: 46449374
Book value: 1409516000
P/B ratio: 0.8963523456278609
Market cap (USD): 1263422972.8
Debt to equity: 0.9186380289404306
Current ratio: 0.3646355628490292
Quick ratio: 0.3646355628490292
Interest coverage ratio: 1.3502816815473164
COGS to revenue (%): 36.6104161516849
SG&A to revenue (%): 9.441312968488338
Free cash flow (dilution-adjusted): 108732000
Buyback yield (%): 0
Retained earnings: 112301000
Receivables turnover: 4.333931858647434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.516916360449172
FCF margin (%): 37.85577261190626
Revenue growth (%): -2.1726395237154557
Rule of 40 score: 35.68313308819081
Financial ratios for DEA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.3
Shares outstanding: 46449374
Market cap (USD): 1360966658.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.04
Shares outstanding: 46449374
Market cap (USD): 1163092324.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEA — annual report dated 2024-12-31
Total revenue: 302052000
Gross profit: 200977000
Operating income: 78667000
Net income: 20578000
Capital expenditures: 0
Operating cash flow: 162635000
Depreciation & amortization: 96333000
Net tangible assets: 1159693000
Owner earnings: 116911000
Return on net tangible assets (%): 10.081202525151053
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.04
P/E ratio: 56.521154872193605
Shares outstanding: 46449374
Book value: 1387117000
P/B ratio: 0.8384961938754986
Market cap (USD): 1163092324.96
Debt to equity: 1.1526215885177675
Current ratio: 0.2678291780562724
Quick ratio: 0.2678291780562724
Interest coverage ratio: 1.2600227443819776
COGS to revenue (%): 34.10339941467032
SG&A to revenue (%): 8.094632712248222
Free cash flow (dilution-adjusted): 159427000
Buyback yield (%): 0
Retained earnings: 131854000
Receivables turnover: 2.8697709328950243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.885514400061916
FCF margin (%): 52.781309178552036
Revenue growth (%): 5.161422846737946
Rule of 40 score: 57.942732025289985
Financial ratios for DEA — quarterly report dated 2025-03-31
Total revenue: 78675000
Gross profit: 52919000
Operating income: 20145000
Net income: 3283000
Capital expenditures: 0
Operating cash flow: 24187000
Depreciation & amortization: 26797000
Net tangible assets: 1178028000
Owner earnings: 30080000
Return on net tangible assets (%): 2.5534197828914085
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 23.93
P/E ratio: 84.64312517666768
Shares outstanding: 46449374
Book value: 1398558000
P/B ratio: 0.7947711284194149
Market cap (USD): 1111533519.82
Debt to equity: 1.1448449045373879
Current ratio: 0.6290184772387721
Quick ratio: 0.6290184772387721
Interest coverage ratio: 1.0962072155411655
COGS to revenue (%): 33.39561487130601
SG&A to revenue (%): 7.8995869081665075
Free cash flow (dilution-adjusted): 22766000
Buyback yield (%): 0
Retained earnings: 134981000
Receivables turnover: 0.6883744126834134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6681357139682651
FCF margin (%): 28.936765173180806
Rule of 40 score: 28.936765173180806
Financial ratios for DEA — quarterly report dated 2025-06-30
Total revenue: 84234000
Gross profit: 56538000
Operating income: 21736000
Net income: 4254000
Capital expenditures: 0
Operating cash flow: 38111000
Depreciation & amortization: 28534000
Net tangible assets: 1146323000
Owner earnings: 32788000
Return on net tangible assets (%): 2.860275855932403
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.48
P/E ratio: 126.21509612843306
Shares outstanding: 46449374
Book value: 1386532000
P/B ratio: 0.686088153407206
Market cap (USD): 951283179.52
Debt to equity: 1.2425908669976604
Current ratio: 0.5197395719706206
Quick ratio: 0.5197395719706206
Interest coverage ratio: 1.1464135021097046
COGS to revenue (%): 33.45917325545504
SG&A to revenue (%): 8.081059904551607
Free cash flow (dilution-adjusted): 36716000
Buyback yield (%): 0
Retained earnings: 139052000
Receivables turnover: 0.7839513066785794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6954055754020434
FCF margin (%): 43.588099817175966
Revenue growth (%): 7.065776930409914
Rule of 40 score: 50.65387674758588
Financial ratios for DEA — quarterly report dated 2025-09-30
Total revenue: 86151000
Gross profit: 56622000
Operating income: 21566000
Net income: 1247000
Capital expenditures: 0
Operating cash flow: 154965000
Depreciation & amortization: 28946000
Net tangible assets: 1142849000
Owner earnings: 30193000
Return on net tangible assets (%): 2.6419063235825555
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.59
P/E ratio: 114.16689260701274
Shares outstanding: 46449374
Book value: 1384823000
P/B ratio: 0.724166182003043
Market cap (USD): 1002841984.66
Debt to equity: 1.1834198305487416
Current ratio: 0.33553348903965835
Quick ratio: 0.33553348903965835
Interest coverage ratio: 1.1328465619582917
COGS to revenue (%): 34.76454132859747
SG&A to revenue (%): 6.741651286694293
Free cash flow (dilution-adjusted): 153332000
Buyback yield (%): 0
Retained earnings: 140265000
Receivables turnover: 0.85657612153993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7095638120481738
FCF margin (%): 177.98052257083492
Revenue growth (%): 2.2758031198803335
Rule of 40 score: 180.25632569071524
Financial ratios for DEA — quarterly report dated 2025-12-31
Total revenue: 87039000
Gross profit: 58609000
Operating income: 21748000
Net income: 4773000
Capital expenditures: 0
Operating cash flow: 41931000
Depreciation & amortization: 29620000
Net tangible assets: 1139221000
Owner earnings: 34393000
Return on net tangible assets (%): 3.018992802976771
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.38
P/E ratio: 69.82652814929557
Shares outstanding: 46449374
Book value: 1369565000
P/B ratio: 0.691196286499728
Market cap (USD): 946638242.12
Debt to equity: 1.2166819391558634
Current ratio: 0.22618229068998763
Quick ratio: 0.22618229068998763
Interest coverage ratio: 1.2028761061946902
COGS to revenue (%): 33.12538057652317
SG&A to revenue (%): 8.28479187490665
Free cash flow (dilution-adjusted): 40335000
Buyback yield (%): 0
Retained earnings: 144857000
Receivables turnover: 1.0146889098730458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7625972488571385
FCF margin (%): 46.341295281425566
Revenue growth (%): 1.0307483372218547
Rule of 40 score: 47.37204361864742
Financial ratios for DEA — annual report dated 2025-12-31
Total revenue: 336099000
Gross profit: 224688000
Operating income: 85195000
Net income: 13557000
Capital expenditures: 0
Operating cash flow: 259194000
Depreciation & amortization: 113897000
Net tangible assets: 1139221000
Owner earnings: 127454000
Return on net tangible assets (%): 11.187820449236803
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.38
P/E ratio: 69.82652814929557
Shares outstanding: 46449374
Book value: 1369565000
P/B ratio: 0.691196286499728
Market cap (USD): 946638242.12
Debt to equity: 1.2166819391558634
Current ratio: 0.22618229068998763
Quick ratio: 0.22618229068998763
Interest coverage ratio: 1.1442635721385017
COGS to revenue (%): 33.692453711555224
SG&A to revenue (%): 7.748014721852788
Free cash flow (dilution-adjusted): 253149000
Buyback yield (%): 0
Retained earnings: 144857000
Receivables turnover: 3.9181967614451088
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.987376890582303
FCF margin (%): 75.31977185293619
Revenue growth (%): 11.27190020261412
Rule of 40 score: 86.5916720555503
Financial ratios for E3B.DE — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.440476190476193
Shares outstanding: 1177820111
Market cap (USD): 27608664268.55953
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E3B.DE — annual report dated 2022-06-30
Total revenue: 1199687500
Gross profit: 1102604166.6666667
Operating income: 442604166.6666667
Net income: 249791666.6666667
Capital expenditures: 184583333.33333334
Operating cash flow: 834270833.3333334
Depreciation & amortization: 513125000
Net tangible assets: 1150729166.6666667
Owner earnings: 578333333.3333334
Return on net tangible assets (%): 50.25798859418846
Capex to operating income (%): 41.703930336549774
Buffett classification: The Good
Stock price: 7.843750000000001
P/E ratio: 36.98492675492077
Shares outstanding: 1177820111
Book value: 2979895833.333333
P/B ratio: 3.100285047656169
Market cap (USD): 9238526495.656252
Debt to equity: 1.217289474604118
Current ratio: 1.0464220360204182
Quick ratio: 1.033997881151883
Effective tax rate (%): 13.503751041956097
Interest coverage ratio: 7.069883527454243
COGS to revenue (%): 8.092385169749067
SG&A to revenue (%): 17.087783276895024
Free cash flow (dilution-adjusted): 649687500
Buyback yield (%): 0
Inventory turnover: 7.224806201550388
Receivables turnover: 4.6627530364372465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.501614309978118
FCF margin (%): 54.15472779369628
Rule of 40 score: 54.15472779369628
Financial ratios for E3B.DE — annual report dated 2023-06-30
Total revenue: 1229673913.0434783
Gross profit: 1117391304.347826
Operating income: 623043478.2608695
Net income: 356847826.0869565
Capital expenditures: 218478260.86956522
Operating cash flow: 798804347.8260869
Depreciation & amortization: 581847826.0869565
Net tangible assets: 1514347826.0869565
Owner earnings: 720217391.3043478
Return on net tangible assets (%): 47.55957507895492
Capex to operating income (%): 35.066294487090026
Buffett classification: The Good
Stock price: 5.076086956521739
P/E ratio: 16.754248913706977
Shares outstanding: 1177820111
Book value: 3339239130.434782
P/B ratio: 1.7904429928615608
Market cap (USD): 5978717302.576087
Debt to equity: 1.060772761303343
Current ratio: 1.662175438596491
Quick ratio: 1.6439298245614034
Effective tax rate (%): 13.790958108668603
Interest coverage ratio: 9.112877583465819
COGS to revenue (%): 9.131088128701494
SG&A to revenue (%): 17.91744011314417
Free cash flow (dilution-adjusted): 580326086.9565217
Buyback yield (%): 0
Inventory turnover: 7.946153846153846
Receivables turnover: 5.452048192771084
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.55739515996596
FCF margin (%): 47.193494210200654
Revenue growth (%): 2.4995186699434853
Rule of 40 score: 49.69301288014414
Financial ratios for E3B.DE — annual report dated 2024-06-30
Total revenue: 1304301075.2688172
Gross profit: 1083548387.096774
Operating income: -205806451.6129032
Net income: -333010752.68817204
Capital expenditures: 498064516.12903225
Operating cash flow: 543655913.9784946
Depreciation & amortization: 849462365.5913978
Net tangible assets: 2196344086.0215054
Owner earnings: 18387096.774193466
Buffett classification: The Gruesome
Stock price: 3.225806451612903
Shares outstanding: 1177820111
Book value: 4207419354.83871
P/B ratio: 0.9030285294794141
Market cap (USD): 3799419712.9032254
Debt to equity: 0.8628638605637762
Current ratio: 1.7291475108367267
Quick ratio: 1.677393931433075
Interest coverage ratio: -1.561174551386623
COGS to revenue (%): 16.92497938994229
SG&A to revenue (%): 23.808738664468258
Free cash flow (dilution-adjusted): 45591397.84946236
Buyback yield (%): 0
Inventory turnover: 5.210659898477157
Receivables turnover: 4.4318597004019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.467416947054956
FCF margin (%): 3.4954657873042043
Revenue growth (%): 6.068857884496757
Rule of 40 score: 9.564323671800961
Financial ratios for E3B.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1829479166.6666667
Buffett classification: The Gruesome
Stock price: 1.8229166666666667
Shares outstanding: 1177820111
Book value: 3189791666.666667
P/B ratio: 0.6731060003428907
Market cap (USD): 2147067910.6770835
Debt to equity: 1.0950297171967867
Current ratio: 1.3572854291417167
Quick ratio: 1.2379451623069653
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E3B.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1820117647.0588236
Buffett classification: The Gruesome
Stock price: 3.376470588235294
Shares outstanding: 1177820111
Book value: 3130705882.3529415
P/B ratio: 1.2702806052271616
Market cap (USD): 3976874963.0235295
Debt to equity: 1.1906354515050166
Current ratio: 1.3826805918189728
Quick ratio: 1.2816362053959964
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for E3B.DE — annual report dated 2025-06-30
Total revenue: 1463176470.5882354
Gross profit: 1178705882.3529413
Operating income: -1069647058.8235295
Net income: -1272823529.4117646
Capital expenditures: 457294117.64705884
Operating cash flow: 450705882.3529412
Depreciation & amortization: 1817529411.764706
Net tangible assets: 1820117647.0588236
Owner earnings: 87411764.70588243
Buffett classification: The Gruesome
Stock price: 3.376470588235294
Shares outstanding: 1177820111
Book value: 3130705882.3529415
P/B ratio: 1.2702806052271616
Market cap (USD): 3976874963.0235295
Debt to equity: 1.1906354515050166
Current ratio: 1.3826805918189728
Quick ratio: 1.2816362053959964
Interest coverage ratio: -5.510303030303031
COGS to revenue (%): 19.441987617592666
SG&A to revenue (%): 26.18798745678218
Free cash flow (dilution-adjusted): -6588235.294117647
Buyback yield (%): 0
Inventory turnover: 2.082687338501292
Receivables turnover: 3.7987171655467318
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.541614673253449
FCF margin (%): -0.450269357562113
Revenue growth (%): 12.18088356529752
Rule of 40 score: 11.730614207735407
Financial ratios for E79.AX — annual report dated 2022-06-30
Operating income: -1620713.103448276
Net income: -1605539.3103448276
Capital expenditures: 170699.3103448276
Depreciation & amortization: 21595.862068965518
Net tangible assets: 6950777.24137931
Owner earnings: -1754642.7586206896
Return on net tangible assets (%): -25.24383529621644
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
Shares outstanding: 353555680
Book value: 6950777.24137931
P/B ratio: 3.5079746477372367
Market cap (USD): 24383150.344827585
Debt to equity: 0
Current ratio: 18.59775335620209
Quick ratio: 18.59775335620209
Free cash flow (dilution-adjusted): -1429382.7586206896
Buyback yield (%): 1.8240380129093106
Retained earnings: -6741966.206896552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.317005381784643
Rule of 40 score: 0
Financial ratios for E79.AX — annual report dated 2023-06-30
Operating income: -2770246.357615894
Net income: -2686814.569536424
Capital expenditures: 178023.17880794703
Depreciation & amortization: 45305.29801324503
Net tangible assets: 5050140.397350993
Owner earnings: -2819532.4503311254
Return on net tangible assets (%): -55.83077357235625
Buffett classification: The Gruesome
Stock price: 0.052980132450331126
Shares outstanding: 353555680
Book value: 5050140.397350993
P/B ratio: 3.7090902987157137
Market cap (USD): 18731426.75496689
Debt to equity: 0
Current ratio: 6.056561446850105
Quick ratio: 6.056561446850105
Free cash flow (dilution-adjusted): -2432574.1721854303
Buyback yield (%): 0.34490677677699877
Retained earnings: -9160888.079470199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.85483847278786
Rule of 40 score: 0
Financial ratios for E79.AX — annual report dated 2024-06-30
Operating income: -1902664
Net income: -1824968.6666666667
Capital expenditures: 3230.6666666666665
Depreciation & amortization: 93438.66666666667
Net tangible assets: 3788613.3333333335
Owner earnings: -1734760.6666666667
Return on net tangible assets (%): -45.7888022354705
Buffett classification: The Gruesome
Stock price: 0.02
Shares outstanding: 353555680
Book value: 3788613.3333333335
P/B ratio: 1.8664120557741442
Market cap (USD): 7071113.600000001
Debt to equity: 0
Current ratio: 11.266412564566245
Quick ratio: 11.266412564566245
Free cash flow (dilution-adjusted): -2073036
Buyback yield (%): 0.29042101657085523
Retained earnings: -11046929.333333334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -50.2205908230276
Rule of 40 score: 0
Financial ratios for EMV.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.263157894736842
Shares outstanding: 92938604
Market cap (USD): 210334735.36842105
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMV.AX — annual report dated 2022-06-30
Operating income: -7218739.310344827
Net income: -4213296.551724138
Capital expenditures: 131806.20689655174
Depreciation & amortization: 167821.37931034484
Net tangible assets: 4552635.172413793
Owner earnings: -4177281.379310345
Return on net tangible assets (%): -91.75524111007478
Buffett classification: The Gruesome
Stock price: 1.0344827586206897
Shares outstanding: 92938604
Book value: 4883669.655172414
P/B ratio: 19.686709019404713
Market cap (USD): 96143383.44827586
Debt to equity: 0.10419849629751284
Current ratio: 8.277406972850054
Quick ratio: 8.277406972850054
Interest coverage ratio: -577.5947467166978
Free cash flow (dilution-adjusted): -2740107.5862068967
Buyback yield (%): 0
Retained earnings: -15026311.724137932
Capitalized R&D asset: 1603699.3103448276
ROCI (R&D-adjusted, %): -89.36296074185309
Rule of 40 score: 0
Financial ratios for EMV.AX — annual report dated 2023-06-30
Operating income: -7237196.688741722
Net income: -2563380.794701987
Capital expenditures: 124035.09933774834
Depreciation & amortization: 226496.02649006623
Net tangible assets: 3069566.2251655627
Owner earnings: -2460919.867549669
Return on net tangible assets (%): -80.17158409465281
Buffett classification: The Gruesome
Stock price: 0.7748344370860927
Shares outstanding: 92938604
Book value: 3387447.0198675497
P/B ratio: 21.258496588006558
Market cap (USD): 72012030.91390727
Debt to equity: 0.5945169592838382
Current ratio: 1.6953574212777323
Quick ratio: 1.6953574212777323
Interest coverage ratio: -309.78164242991187
Free cash flow (dilution-adjusted): 428384.7682119205
Buyback yield (%): 0
Retained earnings: -16992620.529801324
Capitalized R&D asset: 2406746.087599909
ROCI (R&D-adjusted, %): -114.03240598767042
Rule of 40 score: 0
Financial ratios for EMV.AX — annual report dated 2024-06-30
Operating income: -8984378.666666666
Net income: -1819740
Capital expenditures: 76735.33333333333
Depreciation & amortization: 273720
Net tangible assets: 11909113.333333334
Owner earnings: -1622755.3333333333
Return on net tangible assets (%): -13.6261641644746
Buffett classification: The Gruesome
Stock price: 1.4400000000000002
Shares outstanding: 92938604
Book value: 12343832
P/B ratio: 10.841980817626165
Market cap (USD): 133831589.76000002
Debt to equity: 0.15663990458284482
Current ratio: 6.404623767871447
Quick ratio: 6.404623767871447
Interest coverage ratio: -116.45942325806479
Free cash flow (dilution-adjusted): -4196080.666666667
Buyback yield (%): 0
Retained earnings: -17677166.666666668
Capitalized R&D asset: 4553317.364025272
ROCI (R&D-adjusted, %): -43.13376534311004
Rule of 40 score: 0
Financial ratios for GBTG — annual report dated 2022-12-31
Total revenue: 2230120481.927711
Gross profit: 1227710843.3734941
Operating income: -242168674.6987952
Net income: -30120481.927710846
Capital expenditures: 113253012.04819277
Operating cash flow: -474698795.1807229
Depreciation & amortization: 219277108.43373495
Net tangible assets: -2014457831.3253014
Owner earnings: 75903614.45783135
Buffett classification: The Gruesome
Stock price: 6.75
Shares outstanding: 522285480
Book value: 1651807228.9156623
P/B ratio: 2.134284756892779
Market cap (USD): 3525426990
Debt to equity: 0.9482129832239244
Current ratio: 1.5963777490297542
Quick ratio: 1.5963777490297542
Interest coverage ratio: -2.0510204081632653
COGS to revenue (%): 44.94867639113992
R&D to revenue (%): 20.961642355483523
SG&A to revenue (%): 35.116153430578066
Free cash flow (dilution-adjusted): -634939759.0361446
Buyback yield (%): 5.741421936360023
Retained earnings: -210843373.4939759
Receivables turnover: 2.0844594594594597
Capitalized R&D asset: 467469879.5180723
ROCI (R&D-adjusted, %): 1.7249975072290356
FCF margin (%): -28.47109670448406
Rule of 40 score: -28.47109670448406
Financial ratios for GBTG — annual report dated 2023-12-31
Total revenue: 2898734177.21519
Gross profit: 1682278481.012658
Operating income: 43037974.6835443
Net income: -79746835.44303797
Capital expenditures: 143037974.6835443
Operating cash flow: 205063291.1392405
Depreciation & amortization: 245569620.25316456
Net tangible assets: -703797468.3544303
Owner earnings: 22784810.126582295
Capex to operating income (%): 332.3529411764706
Buffett classification: The Gruesome
Stock price: 6.45
Shares outstanding: 522285480
Book value: 1534177215.1898732
P/B ratio: 2.1957967519306933
Market cap (USD): 3368741346
Debt to equity: 1.1831683168316833
Current ratio: 1.6365824308062575
Quick ratio: 1.6365824308062575
Interest coverage ratio: 0.24113475177304966
COGS to revenue (%): 41.9650655021834
R&D to revenue (%): 18.034934497816593
SG&A to revenue (%): 30.043668122270738
Free cash flow (dilution-adjusted): -32911392.405063294
Buyback yield (%): 0
Retained earnings: -1818987341.7721517
Receivables turnover: 2.7425149700598803
Capitalized R&D asset: 835989629.4036908
ROCI (R&D-adjusted, %): 5.201409822996826
Rosenberg metric: 0.9723998434033662
FCF margin (%): -1.1353711790393013
Revenue growth (%): 29.98105710905497
Rule of 40 score: 28.84568593001567
Financial ratios for GBTG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.69
Shares outstanding: 522285480
Market cap (USD): 4016375341.2000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBTG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.28
Shares outstanding: 522285480
Market cap (USD): 4846809254.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBTG — annual report dated 2024-12-31
Total revenue: 3028750000
Gross profit: 1820000000
Operating income: 160000000
Net income: -167500000
Capital expenditures: 133750000
Operating cash flow: 340000000
Depreciation & amortization: 222500000
Net tangible assets: -787500000
Owner earnings: -78750000
Capex to operating income (%): 83.59375
Buffett classification: The Gruesome
Stock price: 9.28
Shares outstanding: 522285480
Book value: 1321250000
P/B ratio: 3.6683513751371803
Market cap (USD): 4846809254.4
Debt to equity: 1.3831598864711447
Current ratio: 1.6423076923076922
Quick ratio: 1.6423076923076922
Interest coverage ratio: 1.1130434782608696
COGS to revenue (%): 39.909203466776724
R&D to revenue (%): 18.241848947585638
SG&A to revenue (%): 29.21997523730912
Free cash flow (dilution-adjusted): 110000000
Buyback yield (%): 1.4184589570465933
Retained earnings: -1968750000
Receivables turnover: 3.5684830633284244
Capitalized R&D asset: 1057030883.025774
ROCI (R&D-adjusted, %): 4.298506272253149
Rosenberg metric: 0.2634382566585959
FCF margin (%): 3.631861328931077
Revenue growth (%): 4.485262008733622
Rule of 40 score: 8.1171233376647
Financial ratios for GBTG — quarterly report dated 2025-03-31
Total revenue: 806493506.4935064
Gross profit: 506493506.4935065
Operating income: 76623376.62337662
Net income: 97402597.4025974
Capital expenditures: 35064935.064935066
Operating cash flow: 68831168.83116883
Depreciation & amortization: 51948051.948051944
Net tangible assets: -736363636.3636364
Owner earnings: 114285714.2857143
Return on net tangible assets (%): -15.520282186948856
Capex to operating income (%): 45.76271186440678
Buffett classification: The Good
Stock price: 7.26
P/E ratio: 9.73226763432
Shares outstanding: 522285480
Book value: 1463636363.6363635
P/B ratio: 2.5906657411677023
Market cap (USD): 3791792584.7999997
Debt to equity: 1.2937000887311447
Current ratio: 1.5989010989010988
Quick ratio: 1.5989010989010988
Effective tax rate (%): 21.875
Interest coverage ratio: 2.458333333333333
COGS to revenue (%): 37.19806763285025
R&D to revenue (%): 19.323671497584545
SG&A to revenue (%): 27.536231884057973
Free cash flow (dilution-adjusted): 9090909.09090909
Buyback yield (%): 0.03425032539773795
Retained earnings: -1948051948.051948
Receivables turnover: 0.7463942307692307
Capitalized R&D asset: 155844155.84415585
ROCI (R&D-adjusted, %): 4.641068447412354
FCF margin (%): 1.1272141706924315
Rule of 40 score: 1.1272141706924315
Financial ratios for GBTG — quarterly report dated 2025-06-30
Total revenue: 864383561.6438357
Gross profit: 532876712.3287671
Operating income: 63013698.63013699
Net income: 20547945.205479454
Capital expenditures: 41095890.41095891
Operating cash flow: 78082191.78082192
Depreciation & amortization: 58904109.5890411
Net tangible assets: -705479452.0547945
Owner earnings: 38356164.38356165
Return on net tangible assets (%): -5.436893203883495
Capex to operating income (%): 65.21739130434783
Buffett classification: The Good
Stock price: 6.3
P/E ratio: 27.896425495330316
Shares outstanding: 522285480
Book value: 1653424657.5342464
P/B ratio: 1.9900504743330574
Market cap (USD): 3290398524
Debt to equity: 1.2046396023198014
Current ratio: 1.6579234972677594
Quick ratio: 1.6579234972677594
Effective tax rate (%): 61.76470588235294
Interest coverage ratio: 2
COGS to revenue (%): 38.35182250396196
R&D to revenue (%): 19.01743264659271
SG&A to revenue (%): 28.526148969889064
Free cash flow (dilution-adjusted): 9589041.095890407
Buyback yield (%): 0
Retained earnings: -2036986301.369863
Receivables turnover: 0.7380116959064327
Capitalized R&D asset: 268799146.05942005
ROCI (R&D-adjusted, %): 2.7941523031362743
Rosenberg metric: 0.16929223744292238
FCF margin (%): 1.1093502377179074
Revenue growth (%): 7.177993955837925
Rule of 40 score: 8.287344193555832
Financial ratios for GBTG — quarterly report dated 2025-09-30
Total revenue: 910810810.8108108
Gross profit: 545945945.945946
Operating income: 55405405.40540541
Net income: -83783783.78378378
Capital expenditures: 44594594.5945946
Operating cash flow: 95945945.94594595
Depreciation & amortization: 66216216.216216214
Net tangible assets: -1064864864.8648648
Owner earnings: -62162162.16216216
Capex to operating income (%): 80.48780487804879
Buffett classification: The Gruesome
Stock price: 8.08
P/E ratio: 123.5138135315156
Shares outstanding: 522285480
Book value: 2072972972.9729729
P/B ratio: 2.0357557640260757
Market cap (USD): 4220066678.4
Debt to equity: 0.9615384615384616
Current ratio: 1.226928895612708
Quick ratio: 1.226928895612708
Interest coverage ratio: 1.7083333333333335
COGS to revenue (%): 40.0593471810089
R&D to revenue (%): 19.287833827893177
SG&A to revenue (%): 27.299703264094955
Free cash flow (dilution-adjusted): 25675675.675675675
Buyback yield (%): 1.0567272508476628
Retained earnings: -2093243243.2432432
Receivables turnover: 0.617781851512374
Capitalized R&D asset: 337241233.405617
ROCI (R&D-adjusted, %): 1.320037711990682
Rosenberg metric: 0.0795045045045047
FCF margin (%): 2.8189910979228485
Revenue growth (%): 5.371139760997123
Rule of 40 score: 8.190130858919972
Financial ratios for GBTG — annual report dated 2025-12-31
Total revenue: 3672972972.972973
Gross profit: 2206756756.756757
Operating income: 245945945.94594595
Net income: 150000000
Capital expenditures: 174324324.32432434
Operating cash flow: 314864864.8648649
Depreciation & amortization: 259459459.45945945
Net tangible assets: -1235135135.1351352
Owner earnings: 235135135.13513508
Return on net tangible assets (%): -19.037199124726474
Capex to operating income (%): 70.87912087912088
Buffett classification: The Good
Stock price: 7.65
P/E ratio: 26.636559480000003
Shares outstanding: 522285480
Book value: 2244594594.594595
P/B ratio: 1.7800470212402166
Market cap (USD): 3995483922
Debt to equity: 0.9066827212522576
Current ratio: 1.1361332367849384
Quick ratio: 1.1361332367849384
Effective tax rate (%): 27.210884353741495
Interest coverage ratio: 1.9157894736842105
COGS to revenue (%): 39.91905813097866
R&D to revenue (%): 19.38925680647535
SG&A to revenue (%): 26.93156732891832
Free cash flow (dilution-adjusted): 37837837.837837845
Buyback yield (%): 2.469003769617688
Retained earnings: -1981081081.0810812
Receivables turnover: 2.680473372781065
Capitalized R&D asset: 1254856149.5039344
ROCI (R&D-adjusted, %): 6.006290905767959
Rosenberg metric: 0.7000122294239942
FCF margin (%): 1.0301692420897721
Revenue growth (%): 21.270259115905006
Rule of 40 score: 22.30042835799478
Financial ratios for GBTG — quarterly report dated 2025-12-31
Total revenue: 1070270270.2702702
Gross profit: 608108108.1081082
Operating income: 48648648.64864865
Net income: 112162162.16216217
Capital expenditures: 52702702.7027027
Operating cash flow: 70270270.27027027
Depreciation & amortization: 81081081.08108108
Net tangible assets: -1235135135.1351352
Owner earnings: 140540540.54054055
Return on net tangible assets (%): -11.37855579868709
Capex to operating income (%): 108.33333333333333
Buffett classification: The Gruesome
Stock price: 7.65
P/E ratio: 27.30481366953999
Shares outstanding: 522285480
Book value: 2244594594.594595
P/B ratio: 1.7800470212402166
Market cap (USD): 3995483922
Debt to equity: 0.9066827212522576
Current ratio: 1.1361332367849384
Quick ratio: 1.1361332367849384
Effective tax rate (%): -45.6140350877193
Interest coverage ratio: 1.5
COGS to revenue (%): 43.18181818181819
R&D to revenue (%): 19.82323232323232
SG&A to revenue (%): 24.873737373737374
Free cash flow (dilution-adjusted): -6756756.756756756
Buyback yield (%): 1.319056808425888
Retained earnings: -1981081081.0810812
Receivables turnover: 0.7810650887573963
Capitalized R&D asset: 384111440.20733064
ROCI (R&D-adjusted, %): 1.4868233330834568
Rosenberg metric: 0.3538461538461539
FCF margin (%): -0.6313131313131313
Revenue growth (%): 17.50741839762611
Rule of 40 score: 16.87610526631298
Financial ratios for GSJ.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.886363636363636
Shares outstanding: 65026083
Market cap (USD): 317741087.3863636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSJ.MC — annual report dated 2022-12-31
Total revenue: 1161928723.4042554
Gross profit: 339588297.87234044
Operating income: 52450000
Net income: 17673404.25531915
Capital expenditures: 6314893.617021277
Operating cash flow: 33622340.42553192
Depreciation & amortization: 9692553.191489363
Net tangible assets: 156810638.29787233
Owner earnings: 21051063.829787232
Return on net tangible assets (%): 13.424512557495827
Capex to operating income (%): 12.039835304139707
Buffett classification: The Great
Stock price: 3.787234042553192
P/E ratio: 13.934440226328782
Shares outstanding: 65026083
Book value: 219737234.0425533
P/B ratio: 1.1207431287853475
Market cap (USD): 246268995.1914894
Debt to equity: 0.06585718919599326
Current ratio: 1.2569756680769582
Quick ratio: 1.13585630051835
Effective tax rate (%): 39.181979845880264
Interest coverage ratio: 13.081188644202706
COGS to revenue (%): 70.77374101937993
R&D to revenue (%): 0.002655159753637798
SG&A to revenue (%): 2.6549766391720295
Free cash flow (dilution-adjusted): 26845744.680851065
Buyback yield (%): 0
Retained earnings: 17673404.25531915
Inventory turnover: 10.200984467582511
Receivables turnover: 3.9955260298728046
Capitalized R&D asset: 30851.063829787236
ROCI (R&D-adjusted, %): 13.970234875028206
FCF margin (%): 2.3104467718293042
Rule of 40 score: 2.3104467718293042
Financial ratios for GSJ.MC — annual report dated 2023-12-31
Total revenue: 1484261111.1111112
Gross profit: 397775555.5555555
Operating income: 54580000
Net income: 23791111.111111112
Capital expenditures: 5644444.444444444
Operating cash flow: 114867777.77777778
Depreciation & amortization: 13152222.222222222
Net tangible assets: 173242222.2222222
Owner earnings: 31298888.88888889
Return on net tangible assets (%): 18.066547800767072
Capex to operating income (%): 10.341598469117706
Buffett classification: The Great
Stock price: 3.5444444444444443
P/E ratio: 9.687708050158788
Shares outstanding: 65026083
Book value: 241020000
P/B ratio: 0.9562747433131413
Market cap (USD): 230481338.63333333
Debt to equity: 0.056311601619044985
Current ratio: 1.2478386543387496
Quick ratio: 1.157628747268127
Effective tax rate (%): 32.78292261811333
Interest coverage ratio: 13.59966777408638
COGS to revenue (%): 73.20043268816883
R&D to revenue (%): 0.000748595447791082
SG&A to revenue (%): 2.310240411428058
Free cash flow (dilution-adjusted): 108743333.33333333
Buyback yield (%): 0
Retained earnings: 22160000
Inventory turnover: 14.151656367136054
Receivables turnover: 3.621395439622851
Capitalized R&D asset: 31781.323877068564
ROCI (R&D-adjusted, %): 13.2557904168717
Rosenberg metric: 1886.0697318007647
FCF margin (%): 7.32642878798654
Revenue growth (%): 27.741149798111213
Rule of 40 score: 35.06757858609775
Financial ratios for GSJ.MC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.644444444444444
Shares outstanding: 65026083
Market cap (USD): 302010029.9333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSJ.MC — annual report dated 2024-12-31
Total revenue: 1622672916.6666667
Gross profit: 409952083.3333334
Operating income: 61291666.66666667
Net income: 34398958.333333336
Capital expenditures: 5456250
Operating cash flow: 127505208.33333334
Depreciation & amortization: 14722916.666666668
Net tangible assets: 202733333.33333334
Owner earnings: 43665625
Return on net tangible assets (%): 21.538453633673132
Capex to operating income (%): 8.90210740992522
Buffett classification: The Great
Stock price: 5.15625
P/E ratio: 9.747119003421856
Shares outstanding: 65026083
Book value: 263230208.33333325
P/B ratio: 1.273754796577774
Market cap (USD): 335290740.46875
Debt to equity: 0.04637496487944252
Current ratio: 1.2191998139207176
Quick ratio: 1.1343959875525609
Effective tax rate (%): 31.801532502526104
Interest coverage ratio: 18.27896862379621
COGS to revenue (%): 74.73600014379568
R&D to revenue (%): 0.0008987229147381572
SG&A to revenue (%): 2.0196871673922785
Free cash flow (dilution-adjusted): 121308333.33333334
Buyback yield (%): 0
Retained earnings: 34398958.333333336
Inventory turnover: 15.500918701568452
Receivables turnover: 3.88234091973961
Capitalized R&D asset: 32208.62884160757
ROCI (R&D-adjusted, %): 14.05939974454927
Rosenberg metric: 1095.8875000000066
FCF margin (%): 7.475833982767631
Revenue growth (%): 9.325300280348998
Rule of 40 score: 16.80113426311663
Financial ratios for GSJ.MC — quarterly report dated 2024-12-31
Operating income: 27757291.666666668
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.15625
Shares outstanding: 65026083
Market cap (USD): 335290740.46875
Interest coverage ratio: 6.768351536703073
Buyback yield (%): 0
Retained earnings: 34398958.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GSJ.MC — quarterly report dated 2025-03-31
Total revenue: 398565217.3913043
Gross profit: 110811956.52173913
Operating income: 17454347.826086957
Net income: 11492391.304347826
Capital expenditures: 0
Depreciation & amortization: 3980434.7826086953
Net tangible assets: 223390217.39130434
Owner earnings: 15472826.086956521
Return on net tangible assets (%): 6.926366905249637
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.804347826086956
P/E ratio: 8.21051932327627
Shares outstanding: 65026083
Book value: 286252173.9130435
P/B ratio: 1.3185367235487102
Market cap (USD): 377434003.5
Debt to equity: 0.4579042498253288
Current ratio: 1.2283622961689888
Quick ratio: 1.116079824937074
Effective tax rate (%): 31.375348867397935
COGS to revenue (%): 72.1972837351369
Buyback yield (%): 0
Inventory turnover: 2.6363889857093064
Receivables turnover: 0.7427709073967164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7157018367941954
Rule of 40 score: 0
Financial ratios for GSJ.MC — quarterly report dated 2025-06-30
Total revenue: 458900000
Gross profit: 128157647.05882353
Operating income: 18947058.82352941
Net income: 8047058.823529412
Capital expenditures: 0
Depreciation & amortization: 3842352.941176471
Net tangible assets: 224601176.47058824
Owner earnings: 11889411.764705883
Return on net tangible assets (%): 5.2935661119579285
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.011764705882353
P/E ratio: 23.33471979800849
Shares outstanding: 65026083
Book value: 294036470.58823514
P/B ratio: 1.5506497980642666
Market cap (USD): 455947593.7411765
Debt to equity: 0.04975373203004032
Current ratio: 1.1958211472949734
Quick ratio: 1.1047451611843186
Effective tax rate (%): 26.954293037163605
COGS to revenue (%): 72.07285965159653
Buyback yield (%): 0
Retained earnings: 19772941.17647059
Inventory turnover: 3.381172876626657
Receivables turnover: 1.0835831178103046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8726137317280216
Revenue growth (%): 15.137994982000663
Rule of 40 score: 15.137994982000663
Financial ratios for GSJ.MC — quarterly report dated 2025-09-30
Total revenue: 461121176.47058827
Gross profit: 124390588.23529412
Operating income: 18417647.05882353
Net income: 12681176.470588235
Capital expenditures: 0
Depreciation & amortization: 6823529.4117647065
Net tangible assets: 237974117.64705884
Owner earnings: 19504705.88235294
Return on net tangible assets (%): 8.196145898219282
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.647058823529412
P/E ratio: 15.432917800189154
Shares outstanding: 65026083
Book value: 310374117.64705896
P/B ratio: 1.6021254785496055
Market cap (USD): 497258281.7647059
Debt to equity: 0.466450355927192
Current ratio: 1.2017857723880165
Quick ratio: 1.1069301277455963
Effective tax rate (%): 25.275451740855004
COGS to revenue (%): 73.02431669103183
Buyback yield (%): 0
Inventory turnover: 3.167072388076216
Receivables turnover: 0.797076898673684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.635548722855305
Revenue growth (%): 0.48402189378693977
Rule of 40 score: 0.48402189378693977
Financial ratios for GSJ.MC — quarterly report dated 2025-12-31
Total revenue: 978101176.4705882
Gross profit: 267554117.64705884
Operating income: 39311764.705882356
Net income: 27570588.23529412
Capital expenditures: 0
Depreciation & amortization: 12649411.764705883
Net tangible assets: 264109411.7647059
Owner earnings: 40220000
Return on net tangible assets (%): 15.22853719269643
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.647058823529411
P/E ratio: 9.404130127277933
Shares outstanding: 65026083
Book value: 338615294.11764693
P/B ratio: 1.6605403669963839
Market cap (USD): 562284364.7647059
Debt to equity: 0.06286155032780566
Current ratio: 1.2366313321993112
Quick ratio: 1.1510787038957806
Effective tax rate (%): 32.532028213617394
Interest coverage ratio: 7.100509987250319
COGS to revenue (%): 72.64555814026218
Buyback yield (%): 0
Retained earnings: 46883529.4117647
Inventory turnover: 7.3222967156868695
Receivables turnover: 2.328368826105952
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.13742561399162
Revenue growth (%): 112.11369730554426
Rule of 40 score: 112.11369730554426
Financial ratios for GSJ.MC — annual report dated 2025-12-31
Total revenue: 1868389411.764706
Gross profit: 515649411.7647059
Operating income: 83220000
Net income: 48056470.5882353
Capital expenditures: 6857647.05882353
Operating cash flow: 188634117.6470588
Depreciation & amortization: 20800000
Net tangible assets: 264109411.7647059
Owner earnings: 61998823.52941176
Return on net tangible assets (%): 23.474674043288655
Capex to operating income (%): 8.240383392001357
Buffett classification: The Great
Stock price: 8.647058823529411
P/E ratio: 11.700492314189189
Shares outstanding: 65026083
Book value: 338615294.11764693
P/B ratio: 1.6605403669963839
Market cap (USD): 562284364.7647059
Debt to equity: 0.06286155032780566
Current ratio: 1.2366313321993112
Quick ratio: 1.1510787038957806
Effective tax rate (%): 31.354821362551675
Interest coverage ratio: 22.75965250965251
COGS to revenue (%): 72.40139509901891
R&D to revenue (%): 0.0003148354890119266
SG&A to revenue (%): 2.263100462115531
Free cash flow (dilution-adjusted): 179874117.6470588
Buyback yield (%): 0
Retained earnings: 46883529.4117647
Inventory turnover: 13.940193736891239
Receivables turnover: 4.447699037718306
Capitalized R&D asset: 19319.852941176472
ROCI (R&D-adjusted, %): 15.10801130838393
Rosenberg metric: 7247.816806722687
FCF margin (%): 9.6272284843001
Revenue growth (%): 15.142700206200264
Rule of 40 score: 24.769928690500365
Financial ratios for GUD.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 37728346.45669291
Buffett classification: The Gruesome
Stock price: 4.173228346456693
Shares outstanding: 98179361
Market cap (USD): 409724892.3622047
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0